tiprankstipranks
Trending News
More News >
Rallybio Corporation (RLYB)
:RLYB
US Market

Rallybio (RLYB) Income Statement

Compare
321 Followers

Rallybio Income Statement

Last quarter (Q4 2024), Rallybio's total revenue was $38.00K, a decrease of -83.33% from the same quarter last year. In Q4, Rallybio's net income was $-11.04M. See Rallybio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 636.00K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 636.00K$ -150.00K$ -167.00K$ -109.00K$ -62.03K
Operating Expenses
$ 61.13M$ 78.93M$ 67.88M$ 45.65M$ 25.30M
Depreciation and Amortization
$ 0.00$ 150.00K$ 167.00K$ 109.00K$ 62.03K
EBITDA
$ -60.50M$ -72.37M$ -65.41M$ -45.39M$ -24.83M
Operating Income
$ -60.50M$ -78.93M$ -67.88M$ -45.65M$ -25.30M
Other Income/Expenses
$ 2.72M$ 4.37M$ 2.31M$ 140.00K$ 363.00K
Pretax Income
$ -57.77M$ -74.56M$ -65.58M$ -45.51M$ -24.94M
Net Income
$ -57.77M$ -74.56M$ -66.49M$ -47.01M$ -24.93M
Per Share Metrics
Basic EPS
$ -1.33$ -1.84$ -2.09$ -1.46$ -0.78
Diluted EPS
$ -1.33$ -1.84$ -2.09$ -1.46$ -0.78
Weighted Average Shares Outstanding
43.54M 40.45M 31.82M 32.13M 32.13M
Weighted Average Shares Outstanding (Diluted)
43.54M 40.45M 31.82M 32.13M 32.13M
Currency in USD

Rallybio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis